Atif Ishfaq
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Atif Ishfaq has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Fahad Amin
King Edward Medical University, Lahore, Pakistan
3 shared publications - Abdullah Imtiaz
King Edward Medical University, Neela Gumbad, Lahore, Pakistan
2 shared publications - Fatima Tu Zahra
King Edward Medical University, Neela Gumbad, Lahore, Pakistan
2 shared publications - Rija Fatima
King Edward Medical University , Lahore
2 shared publications - Tahzeeb Afzal
King Edward Medical University, Neela Gumbad, Lahore, Pakistan.
2 shared publications - Abu-Bakr Ahmed
Kirk Kerkorian School of Medicine at UNLV
1 shared publication
Latest Publications
- 4 June 2026
- Published by Springer Nature in Pediatric Surgery International
- Vol. 42 (1)
Interrupted vs. continuous suture urethroplasty in tubularised incised plate hypospadias: an updated systematic review & meta-analysis
The optimal suturing technique for urethral tubularisation during tubularised incised plate (TIP) urethroplasty remains debated. This systematic review and meta-analysis compared perioperative and postoperative outcomes of interrupted versus continuous suturing techniques in paediatric hypospadias repair. A systematic literature search was performed in PubMed, Cochrane Library, Embase, Scopus, and ClinicalTrials.gov from inception to December 2025 in accordance with PRISMA guidelines. Randomised controlled trials and observational studies comparing interrupted and continuous suturing during paediatric TIP urethroplasty were included. Outcomes assessed were urethrocutaneous fistula, surgical site infection, meatal stenosis, urethral stricture, glans dehiscence, overall complications, urinary stream outcomes, operative time, and reoperation rates. Risk of bias was evaluated using the Cochrane Risk of Bias 2.0 tool and the ROBINS-I. A random-effects meta-analysis supplemented by influence diagnostics and Hartung-Knapp adjustment for heterogeneous outcomes, were conducted using R version 4.5.2, with results expressed as odds ratios (ORs) or mean differences (MDs) and corresponding 95% confidence intervals (CIs). Fifteen studies involving 2625 paediatric patients were included, with 800 undergoing interrupted suturing and 1,825 continuous suturing. No statistically significant differences were observed between techniques for urethrocutaneous fistula (OR 0.65, 95% CI 0.38-1.11), surgical site infection (OR 0.61, 95% CI 0.25-1.48), meatal stenosis (OR 0.98, 95% CI 0.54-1.80), urethral stricture (OR 1.08, 95% CI 0.29-3.97), overall complications (OR 0.75, 95% CI 0.48-1.17), or glans dehiscence (OR 0.77, 95% CI 0.36-1.63). Operating time showed no clinically meaningful difference operative time (MD 3.77 min, 95% CI - 3.69 to 11.24, Hartung-Knapp adjusted). Continuous and interrupted suturing techniques during TIP urethroplasty demonstrate comparable complication rates and functional outcomes. These findings suggest that suturing technique may be selected based on surgeon preference and experience; however, large, well-designed multicentre randomised trials are required to further inform clinical practice.
- 4 June 2026
- Published by Springer Nature in Pediatric Surgery International
- Vol. 42 (1)
Interrupted vs. continuous suture urethroplasty in tubularised incised plate hypospadias: an updated systematic review & meta-analysis
The optimal suturing technique for urethral tubularisation during tubularised incised plate (TIP) urethroplasty remains debated. This systematic review and meta-analysis compared perioperative and postoperative outcomes of interrupted versus continuous suturing techniques in paediatric hypospadias repair. A systematic literature search was performed in PubMed, Cochrane Library, Embase, Scopus, and ClinicalTrials.gov from inception to December 2025 in accordance with PRISMA guidelines. Randomised controlled trials and observational studies comparing interrupted and continuous suturing during paediatric TIP urethroplasty were included. Outcomes assessed were urethrocutaneous fistula, surgical site infection, meatal stenosis, urethral stricture, glans dehiscence, overall complications, urinary stream outcomes, operative time, and reoperation rates. Risk of bias was evaluated using the Cochrane Risk of Bias 2.0 tool and the ROBINS-I. A random-effects meta-analysis supplemented by influence diagnostics and Hartung-Knapp adjustment for heterogeneous outcomes, were conducted using R version 4.5.2, with results expressed as odds ratios (ORs) or mean differences (MDs) and corresponding 95% confidence intervals (CIs). Fifteen studies involving 2625 paediatric patients were included, with 800 undergoing interrupted suturing and 1,825 continuous suturing. No statistically significant differences were observed between techniques for urethrocutaneous fistula (OR 0.65, 95% CI 0.38-1.11), surgical site infection (OR 0.61, 95% CI 0.25-1.48), meatal stenosis (OR 0.98, 95% CI 0.54-1.80), urethral stricture (OR 1.08, 95% CI 0.29-3.97), overall complications (OR 0.75, 95% CI 0.48-1.17), or glans dehiscence (OR 0.77, 95% CI 0.36-1.63). Operating time showed no clinically meaningful difference operative time (MD 3.77 min, 95% CI - 3.69 to 11.24, Hartung-Knapp adjusted). Continuous and interrupted suturing techniques during TIP urethroplasty demonstrate comparable complication rates and functional outcomes. These findings suggest that suturing technique may be selected based on surgeon preference and experience; however, large, well-designed multicentre randomised trials are required to further inform clinical practice.
- 15 May 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1)
Comparative outcomes of da Vinci SP versus da Vinci Xi platforms in robotic cholecystectomy: a systematic review and meta-analysis
As robotic cholecystectomy adoption accelerates, the evidence comparing the perioperative outcomes of the Da Vinci Xi (DV-Xi) multiport platform to the Da Vinci Single-Port (DV-Sp) platform remains scarce. This meta-analysis provides the first systematic comparison of perioperative outcomes between these platforms. To compare perioperative safety and operative efficiency outcomes between the DV-Sp and the DV-Xi systems performing cholecystectomy. We thoroughly searched PubMed, Embase, Scopus, Cochrane Library, and ClinicalTrials.gov from inception till December 22, 2025. The key outcomes of interest included mean operative time, console time, docking time, pain scores on the day of the operation, pain scores after 24 h, estimated blood loss, and length of hospital stay. We conducted random-effects meta-analysis and leave-one-out sensitivity analysis using RStudio v 4.5.2. The ROBINS-I was used for the risk of bias assessment. A GRADE assessment through GRADEpro was performed. Four observational studies comprising 833 patients (DV-Sp: n = 416; DV-Xi: n = 417) met the set inclusion criteria, and no RCTs were found. The DV-Sp showed significantly decreased mean operative time (MD = -2.41 min; 95% CI - 4.09 to - 0.73, p = 0.0049) and console time (MD = - 7.24; 95% CI - 9.77 to - 4.72, P < 0.0001) with no heterogeneity (I² = 0%). Two studies reported reduced pain scores in the DV-SP group. There was no significant difference found in the pooled estimates of post-operative pain scores, blood loss, docking time, and length of hospital stay between the two platforms. The DV-Sp demonstrated modest but consistent reductions in operative and console time with comparable safety to the DV-Xi system. Pain scores on the day of surgery and after 24 h of operation were reported low in the DV-SP group. While the magnitude of time differences is unlikely to impact individual patient outcomes, cumulative reductions across high-volume operating centers may translate into meaningful gains in operating room efficiency. However, substantial heterogeneity, particularly in pain-related outcomes and docking time, warrants cautious interpretation of these outcomes.
- 15 May 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1)
Comparative outcomes of da Vinci SP versus da Vinci Xi platforms in robotic cholecystectomy: a systematic review and meta-analysis
As robotic cholecystectomy adoption accelerates, the evidence comparing the perioperative outcomes of the Da Vinci Xi (DV-Xi) multiport platform to the Da Vinci Single-Port (DV-Sp) platform remains scarce. This meta-analysis provides the first systematic comparison of perioperative outcomes between these platforms. To compare perioperative safety and operative efficiency outcomes between the DV-Sp and the DV-Xi systems performing cholecystectomy. We thoroughly searched PubMed, Embase, Scopus, Cochrane Library, and ClinicalTrials.gov from inception till December 22, 2025. The key outcomes of interest included mean operative time, console time, docking time, pain scores on the day of the operation, pain scores after 24 h, estimated blood loss, and length of hospital stay. We conducted random-effects meta-analysis and leave-one-out sensitivity analysis using RStudio v 4.5.2. The ROBINS-I was used for the risk of bias assessment. A GRADE assessment through GRADEpro was performed. Four observational studies comprising 833 patients (DV-Sp: n = 416; DV-Xi: n = 417) met the set inclusion criteria, and no RCTs were found. The DV-Sp showed significantly decreased mean operative time (MD = -2.41 min; 95% CI - 4.09 to - 0.73, p = 0.0049) and console time (MD = - 7.24; 95% CI - 9.77 to - 4.72, P < 0.0001) with no heterogeneity (I² = 0%). Two studies reported reduced pain scores in the DV-SP group. There was no significant difference found in the pooled estimates of post-operative pain scores, blood loss, docking time, and length of hospital stay between the two platforms. The DV-Sp demonstrated modest but consistent reductions in operative and console time with comparable safety to the DV-Xi system. Pain scores on the day of surgery and after 24 h of operation were reported low in the DV-SP group. While the magnitude of time differences is unlikely to impact individual patient outcomes, cumulative reductions across high-volume operating centers may translate into meaningful gains in operating room efficiency. However, substantial heterogeneity, particularly in pain-related outcomes and docking time, warrants cautious interpretation of these outcomes.
- Open Access
- 8 April 2026
- Published by Elsevier in SSRN Electronic Journal
Do RCT-Proven Benefits of Minimally Invasive Surgery for Spontaneous Intracerebral Hemorrhage Translate into Real-World Settings? A GRADE-Assessed Systematic Review and Meta-Analysis
Background: Intracerebral hemorrhage is a highly lethal stroke subtype, yet uncertainty persists over the optimal surgical approach. Previous meta-analyses comparing minimally invasive surgery (MIS) with conventional craniotomy (CC) were confined to randomized trials, underpowered for several endpoints, and did not address real-world translatability or the full burden of complications.Methods: In this systematic review and meta-analysis, we searched PubMed, Embase, Scopus, the Cochrane Library, ClinicalTrials.gov, and grey literature from January 2000 to January 10, 2026. We included randomized and observational studies enrolling adults with spontaneous, non-traumatic intracerebral hemorrhage undergoing MIS versus CC. Two reviewers independently extracted summary data and assessed risk of bias. Outcomes were pooled using random-effects models, and meta-regression and sensitivity analyses were performed. GRADE certainty was rated separately for randomized, observational, and overall evidence pools, and trial sequential analysis was applied to functional outcomes and mortality.Findings: 76 studies involving 35,271 patients were included. In randomized trials, MIS improved favorable functional outcome (high certainty; RR 1·40, 95% CI 1·21–1·62; I²=35%), with trial sequential analysis confirming evidential sufficiency. This benefit was not clearly reproduced in observational data (RR 1·22, 0·95–1·57), indicating incomplete translation into routine practice. MIS also reduced mortality (moderate certainty; RR 0·73, 0·64–0·84), rebleeding (high certainty; RR 0·74, 0·60–0·92), systemic and surgery-related neurological complications, all with high certainty. ICU/hospital stay and blood loss also favoured MIS. Haematoma clearance was similar between groups.Interpretation: Extending prior trial-dominant literature, this synthesis demonstrates that MIS offers broader functional and safety advantages over CC, while revealing that trial efficacy does not automatically translate into routine care. Selective implementation, guided by patient severity, technique choice, and system-level standardization, is essential. Endoscopic and port-based MIS for patients with intermediate severity were most beneficial. Functional benefit warrants guideline reappraisal. Definitive mortality evidence requires adequately powered trials with prospectively designated mortality endpoints.
- 8 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessDo RCT-Proven Benefits of Minimally Invasive Surgery for Spontaneous Intracerebral Hemorrhage Translate into Real-World Settings? A GRADE-Assessed Systematic Review and Meta-Analysis
Background: Intracerebral hemorrhage is a highly lethal stroke subtype, yet uncertainty persists over the optimal surgical approach. Previous meta-analyses comparing minimally invasive surgery (MIS) with conventional craniotomy (CC) were confined to randomized trials, underpowered for several endpoints, and did not address real-world translatability or the full burden of complications.Methods: In this systematic review and meta-analysis, we searched PubMed, Embase, Scopus, the Cochrane Library, ClinicalTrials.gov, and grey literature from January 2000 to January 10, 2026. We included randomized and observational studies enrolling adults with spontaneous, non-traumatic intracerebral hemorrhage undergoing MIS versus CC. Two reviewers independently extracted summary data and assessed risk of bias. Outcomes were pooled using random-effects models, and meta-regression and sensitivity analyses were performed. GRADE certainty was rated separately for randomized, observational, and overall evidence pools, and trial sequential analysis was applied to functional outcomes and mortality.Findings: 76 studies involving 35,271 patients were included. In randomized trials, MIS improved favorable functional outcome (high certainty; RR 1·40, 95% CI 1·21–1·62; I²=35%), with trial sequential analysis confirming evidential sufficiency. This benefit was not clearly reproduced in observational data (RR 1·22, 0·95–1·57), indicating incomplete translation into routine practice. MIS also reduced mortality (moderate certainty; RR 0·73, 0·64–0·84), rebleeding (high certainty; RR 0·74, 0·60–0·92), systemic and surgery-related neurological complications, all with high certainty. ICU/hospital stay and blood loss also favoured MIS. Haematoma clearance was similar between groups.Interpretation: Extending prior trial-dominant literature, this synthesis demonstrates that MIS offers broader functional and safety advantages over CC, while revealing that trial efficacy does not automatically translate into routine care. Selective implementation, guided by patient severity, technique choice, and system-level standardization, is essential. Endoscopic and port-based MIS for patients with intermediate severity were most beneficial. Functional benefit warrants guideline reappraisal. Definitive mortality evidence requires adequately powered trials with prospectively designated mortality endpoints.